141
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma
Condition(s):NeuroblastomaLast Updated:October 16, 2013Completed
Leukine: 749 Clinical Trials, Page 15 of 75
Hide Studies Not Open or Pending
142
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:November 29, 2017Terminated
143
Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Condition(s):Melanoma (Skin)Last Updated:December 10, 2013Suspended
144
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
Condition(s):HIV InfectionsLast Updated:November 1, 2021Completed
145
SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
Condition(s):Partial Response of Multiple Myeloma or Plasma Cell Leukemia; Plasma Cell MyelomaLast Updated:December 14, 2022Active, not recruiting
146
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:January 17, 2018Completed
147
Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer
Condition(s):Breast Cancer; Breast NeoplasmsLast Updated:March 4, 2008Completed
148
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Condition(s):Recurrent OsteosarcomaLast Updated:December 23, 2022Recruiting
149
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Condition(s):Breast Ductal Carcinoma In SituLast Updated:July 2, 2021Active, not recruiting
150
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Condition(s):LeukemiaLast Updated:April 28, 2015Completed